RayzeBio, Inc. Announces Pricing of Upsized $311 Million Initial Public Offering
15.09.2023 - RayzeBio, Inc. (Nasdaq: RYZB), a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, today announced the pricing of its upsized $311 million initial public offering of 17,277,600 shares of ...